DE60128673D1 - Verfahren zur verbesserung der grösse und des aussehens einer wunde - Google Patents

Verfahren zur verbesserung der grösse und des aussehens einer wunde

Info

Publication number
DE60128673D1
DE60128673D1 DE60128673T DE60128673T DE60128673D1 DE 60128673 D1 DE60128673 D1 DE 60128673D1 DE 60128673 T DE60128673 T DE 60128673T DE 60128673 T DE60128673 T DE 60128673T DE 60128673 D1 DE60128673 D1 DE 60128673D1
Authority
DE
Germany
Prior art keywords
inhibitor
appearance
improving
size
wounce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60128673T
Other languages
English (en)
Inventor
Mary Capelli-Schellpfeffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Avocet Polymer Technologies Inc
Original Assignee
Avocet Polymer Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avocet Polymer Technologies Inc filed Critical Avocet Polymer Technologies Inc
Application granted granted Critical
Publication of DE60128673D1 publication Critical patent/DE60128673D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Lighting Device Outwards From Vehicle And Optical Signal (AREA)
DE60128673T 2000-03-17 2001-03-16 Verfahren zur verbesserung der grösse und des aussehens einer wunde Expired - Lifetime DE60128673D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19019800P 2000-03-17 2000-03-17
PCT/US2001/008735 WO2001070210A2 (en) 2000-03-17 2001-03-16 Methods for improving size and appearance of a wound

Publications (1)

Publication Number Publication Date
DE60128673D1 true DE60128673D1 (de) 2007-07-12

Family

ID=22700387

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60128673T Expired - Lifetime DE60128673D1 (de) 2000-03-17 2001-03-16 Verfahren zur verbesserung der grösse und des aussehens einer wunde

Country Status (7)

Country Link
US (1) US20020013300A1 (de)
EP (1) EP1278517B1 (de)
AT (1) ATE363271T1 (de)
CA (1) CA2406024C (de)
DE (1) DE60128673D1 (de)
ES (1) ES2290120T3 (de)
WO (1) WO2001070210A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038957A1 (es) * 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
JP4868687B2 (ja) * 2002-09-30 2012-02-01 帝國製薬株式会社 ケロイド等の形成抑制外用剤
WO2004111192A2 (en) * 2003-05-29 2004-12-23 The Scripps Research Institute Targeted delivery to legumain-expressing cells
US20050014729A1 (en) * 2003-07-16 2005-01-20 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
US20050106221A1 (en) * 2003-11-14 2005-05-19 Nash Alan E. Kit for the treatment of a corn or a callus
US8062661B2 (en) * 2003-12-11 2011-11-22 Teikoku Pharma Usa, Inc. Methods and compositions for treating skin wounds
AU2004315561B2 (en) * 2004-02-16 2010-10-28 Teikoku Seiyaku Co., Ltd. External preparation for treating painful skin wound
EP2452670A1 (de) 2004-10-01 2012-05-16 Ramscor, Inc. Einfach implantierbare Arzneimittelzusammensetzungen mit verzögerter Freisetzung
EP1919444A2 (de) * 2005-04-27 2008-05-14 Avocet Polymer Technologies, Inc. Zusammensetzungen auf polyethylenglykolbasis für die topische behandlung einer geschlossenen wunde mit therapeutischen pharmazeutika
AU2006274530B2 (en) * 2005-08-01 2009-03-12 Hawk Medical Technologies Ltd. Eradication of pigmentation and scar tissue
DE102005055497A1 (de) 2005-11-18 2007-05-31 Stockhausen Gmbh Geruchsbindende superabsorbierende Zusammensetzung
WO2007120687A2 (en) * 2006-04-11 2007-10-25 Avocet Polymer Technologies, Inc. Combination therapy for the treatment and improvement of scars
EP2054089B1 (de) 2006-08-03 2018-12-26 The Board of Trustees of the Leland Stanford Junior University Vorrichtungen und bandagen zur behandlungen bzw. prävention von narben und/oder keloiden sowie verfahren und kits dafür
HU227970B1 (en) * 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
US9358009B2 (en) 2007-08-03 2016-06-07 Neodyne Biosciences, Inc. Skin straining devices and methods
DE102007045724B4 (de) 2007-09-24 2012-01-26 Evonik Stockhausen Gmbh Superabsorbierende Zusammensetzung mit Tanninen zur Geruchskontrolle, Verfahren zu deren Herstellung und Verwendung
TWI455973B (zh) 2008-03-05 2014-10-11 Evonik Degussa Gmbh 用於氣味控制的具有水楊酸鋅的超吸收性組合物
BRPI0917684A2 (pt) * 2008-08-29 2015-12-01 Nancy Josephine Polich método terapêutico homeopático
US20100274205A1 (en) * 2009-04-24 2010-10-28 Morelli Rocco R Wound care kit
JP5755649B2 (ja) 2009-08-11 2015-07-29 ネオダイン バイオサイエンシーズ， インコーポレイテッド 包帯材アプリケータのための装置及び方法
CN103415272B (zh) 2011-01-07 2015-04-29 尼欧迪纳生物科学公司 伤口或皮肤处理装置和方法
JP6272625B2 (ja) 2011-03-03 2018-01-31 ネオダイン バイオサイエンシーズ， インコーポレイテッド 皮膚引締めのためのデバイスおよび方法
US10022335B2 (en) 2011-03-03 2018-07-17 Nancy Josephine Polich Homeopathic therapeutic method and compositions
US10561359B2 (en) 2011-12-02 2020-02-18 Neodyne Biosciences, Inc. Elastic devices, methods, systems and kits for selecting skin treatment devices
US10213350B2 (en) 2012-02-08 2019-02-26 Neodyne Biosciences, Inc. Radially tensioned wound or skin treatment devices and methods
US10045965B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
CN107249574A (zh) * 2014-09-30 2017-10-13 重庆民济医疗器械有限公司 水凝胶组合物、其制备方法及其应用
US20220379018A1 (en) 2019-12-10 2022-12-01 Neodyne Biosciences, Inc. Tensioned infusion systems with removable hubs

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2113374A (en) * 1936-02-18 1938-04-05 Colgate Palmolive Peet Co Salicylic acid derivatives
US3119739A (en) * 1961-05-03 1964-01-28 Wanda L Campbell Acetylmethyl-salicylate for pain relief
US3419006A (en) * 1966-08-08 1968-12-31 Union Carbide Corp Novel dressing and use thereof
US3664343A (en) * 1969-10-06 1972-05-23 Union Carbide Corp Disposable articles
US3800792A (en) * 1972-04-17 1974-04-02 Johnson & Johnson Laminated collagen film dressing
US3993551A (en) * 1973-09-10 1976-11-23 Union Carbide Corporation Process for cocrosslinking water soluble polymers and products thereof
US4126681A (en) * 1975-12-08 1978-11-21 The Procter & Gamble Company Topical composition containing acetyl salicylic acid
DE2707537A1 (de) * 1976-02-23 1977-08-25 Barnes Hind Pharm Inc Praeparat zur lokalbehandlung der hypertrophischen narbenbildung bei akne
US4244948A (en) * 1979-05-07 1981-01-13 Allergan Pharmaceuticals, Inc. Medical use of esters of acetylsalicylic acid to treat acne
US4346108A (en) * 1981-06-22 1982-08-24 The Upjohn Manufacturing Company M Method for preventing adhesion formation
DE3224382A1 (de) * 1982-06-30 1984-01-12 Beiersdorf Ag, 2000 Hamburg Verbandmaterial auf hydrogelbasis und verfahren zu dessen herstellung
IT1169978B (it) * 1983-12-13 1987-06-03 Bella Agatina Di Preparato per la cura delle ustioni
US4659700A (en) * 1984-03-02 1987-04-21 Johnson & Johnson Products, Inc. Chitosan-glycerol-water gel
GB2192142B (en) * 1986-07-04 1990-11-28 Johnson & Johnson Wound dressing
US4646730A (en) * 1986-05-23 1987-03-03 Johnson & Johnson Products, Inc. Color stabilized hydrogel dressing and process
US4909244B1 (en) * 1986-11-26 1994-07-05 Kendall & Co Hydrogel wound dressing
FR2618337B1 (fr) * 1987-07-22 1989-12-15 Dow Corning Sa Pansement chirurgical et procede pour le fabriquer
US5013769A (en) * 1988-08-22 1991-05-07 Medipro Sciences Limited Method of making a hydrogel-forming wound dressing or skin coating material
US5521087A (en) * 1989-05-10 1996-05-28 Massachusetts Institute Of Technology Method for producing oriented connective tissue cells in a ligament configuration
US5132119A (en) * 1989-07-31 1992-07-21 Massachusetts Institute Of Technology Treatment of hypertrophic wound healing disorders with calcium channel blockers
US5569678A (en) * 1989-07-31 1996-10-29 Massachusetts Institute Of Technology Control of wound scar production
US5552162A (en) * 1993-02-09 1996-09-03 Arch Development Corporation Method for improvement of scar size and appearance
EP0956018A4 (de) * 1996-08-21 2000-01-12 Smithkline Beecham Corp Imidazolverbindungen, deren zusammensetzungen und verwendung
IL145898A0 (en) * 1999-04-22 2002-07-25 Biogen Inc Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
US6521271B1 (en) * 1999-08-16 2003-02-18 Dung Phan Compositions and methods of treatment for skin conditions using extracts of turmeric

Also Published As

Publication number Publication date
EP1278517B1 (de) 2007-05-30
ATE363271T1 (de) 2007-06-15
WO2001070210A3 (en) 2002-10-24
CA2406024A1 (en) 2001-09-27
CA2406024C (en) 2012-05-22
US20020013300A1 (en) 2002-01-31
ES2290120T3 (es) 2008-02-16
WO2001070210A2 (en) 2001-09-27
EP1278517A2 (de) 2003-01-29

Similar Documents

Publication Publication Date Title
DE60128673D1 (de) Verfahren zur verbesserung der grösse und des aussehens einer wunde
HK1071521A1 (en) Use of a composition comprising cis-clomiphene andtrans-clomiphene in the preparation of a medicament for increasing serum levels of testosterone
EE200200328A (et) Multši kompositsioon ja meetod
IL169258A0 (en) Methods of detecting the inhibition of fibrocyte formation and methods and compositions for enhancing fibrocyte formation
DE60014180D1 (de) Zubereitung zur verbesserung der epithelialen lipidbarrierefunktion
PT991619E (pt) Inibidores da adesao celular mediada pela alfa4beta1
DE69525847D1 (de) Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
IL153656A0 (en) Methods and compositions for treating pain of the mucous membrane
NZ531406A (en) Plaster for the treatment of dysfunctions and disorders of nail growth
BR0316203A (pt) Uso de um agente antialérgico e um esteróide para tratar rinite alérgica
ATE371475T1 (de) Methoden zur behandlung der hautpigmentierung
ATE421877T1 (de) Verwendung von totarol zur behandlung von pruritus
WO2007005720A3 (en) Methods and compositions for promoting wound healing
WO2001034172A3 (en) Methods and compositions for treating reward deficiency syndrome
CA2418167A1 (en) Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
ATE541565T1 (de) Topische verwendung von muskarinischen und opioiden mitteln zur behandlung von tinnitus
EE200300305A (et) Geelkompositsioon ja kompositsiooni transskrotaalne kasutamine hüpogonadismi raviks
TW200744660A (en) Oral composition containing morin
DE60118882D1 (de) Verwendung des dheas oder bestimmte seiner derivaten zur verbesserung des papyrus-ähnliches aussehens der haut
SI1575383T1 (sl) Vlažen sestavek njuhanca, ki obsega vsaj eno zgoščevalno sredstvo in postopek za njegovo izdelavo
BR0009194A (pt) Composição do resorcinol
BR0111785A (pt) Composições e métodos para tratamento de candidìase
DE60226313D1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs
ATE274044T1 (de) Zusammensetzungen zur behandlung von gewebe
TWI262791B (en) 6-methoxy-2-naphthylacetic acid prodrugs

Legal Events

Date Code Title Description
8332 No legal effect for de